Comparison of Abbott real time SARS-COV-2 assay and Liferiver Novel Coronavirus Real Time Multiplex kit for the RT-PCR based detection of SARS-COV-2 from nasopharyngeal swabs
Acta Clinica Croatica · 2024
DOI: 10.20471/acc.2024.63.02.3 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Acta Clinica Croatica, 2024. Verfasst von Jelena Stojčević-Maletić und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Nasopharynx, Real-Time Polymerase Chain Reaction. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The objective of this study was to compare performance of two authorized tests, the Abbott Real Time SARS–CoV-2 (ACOV) assay (Abbott Molecular Inc., North Chicago, IL, USA) and Liferiver Novel Coronavirus Real Time Multiplex RT-PCR (Liferiver 2019-nCoV) kit (BioVendor Group, Brno, Czech Republic), and to determine whether the selection of targeted genes has an impact on test specificity. We included 105 nasopharyngeal swabs from adult individuals with symptoms or suspected of coronavirus disease 2019 (COVID-19), aged from 26 to 91 years, previously tested by the ACOV and subsequently tested by the Liferiver 2019-nCoV. In this comparative analysis, we found that the ACOV assay detected more cases of COVID-19 infection than the Liferiver 2019- nCoV assay. The Liferiver 2019-nCoV kit showed a high level of agreement with the ACOV assay. The positive percent agreement was 88.89% (95% confidence intervals (95% CI): 77.42%-100.0%), and the kappa coefficient (kappa) was 0.901 (95% CI: 0.817-0.985). The negative percent agreement was 94.12% (95% CI: 89.74%-98.50%), while 4.76% of SARS-CoV-2 cases were false-negative using the Liferiver test. However, due to the possible false-negative results using the Liferiver 2019-nCOV test, we recommend complete testing with the ACOV assay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia.
- University Clinical Center of Vojvodina, Center for Laboratory Diagnostics, Novi Sad, Serbia.
- Institute of Public Health of Vojvodina, Novi Sad, Serbia.
- Šabac High School of Medical and Business-Technology School of Professional Studies, Šabac, Serbia.
Zitieren
APA
Stojčević-Maletić, J., Barjaktarović, I., Đerić, M., Čabarkapa, V., Petrović, V., Patić, A., & Bogdanović-Vasić, S. (2024). Comparison of Abbott real time SARS-COV-2 assay and Liferiver Novel Coronavirus Real Time Multiplex kit for the RT-PCR based detection of SARS-COV-2 from nasopharyngeal swabs. Acta Clinica Croatica. https://doi.org/10.20471/acc.2024.63.02.3
Vancouver
Stojčević-Maletić J, Barjaktarović I, Đerić M, Čabarkapa V, Petrović V, Patić A, et al. Comparison of Abbott real time SARS-COV-2 assay and Liferiver Novel Coronavirus Real Time Multiplex kit for the RT-PCR based detection of SARS-COV-2 from nasopharyngeal swabs. Acta Clinica Croatica. 2024. doi:10.20471/acc.2024.63.02.3
BibTeX
@article{StojeviMaleti2024,
author = {Stojčević-Maletić, Jelena and Barjaktarović, Iva and Đerić, Mirjana and Čabarkapa, Velibor and Petrović, Vladimir and Patić, Aleksandra and Bogdanović-Vasić, Slobodanka},
title = {Comparison of Abbott real time SARS-COV-2 assay and Liferiver Novel Coronavirus Real Time Multiplex kit for the RT-PCR based detection of SARS-COV-2 from nasopharyngeal swabs},
journal = {Acta Clinica Croatica},
year = {2024},
doi = {10.20471/acc.2024.63.02.3}
}
EUVIMED